#Novartis Q2 Earnings: Core European Markets Dragged Novartis Down

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/6e/33/c4/6e33c438-a718-f70d-492a-6abcf0b16f9e/mza_10839839195084272730.jpg/600x600bb.jpg

Stocks Decoded | Invest and trade with knowledge that drives profits and cuts risks

Robalyst

43 episodes

1 day ago

It's your knowledge that makes money on the markets. There is a new way to learn about stocks, markets and companies. You can access it at robalyst.com for free.

Business

RSS

All content for Stocks Decoded | Invest and trade with knowledge that drives profits and cuts risks is the property of Robalyst and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

It's your knowledge that makes money on the markets. There is a new way to learn about stocks, markets and companies. You can access it at robalyst.com for free.

Business

https://d3t3ozftmdmh3i.cloudfront.net/production/podcast_uploaded/2755042/2755042-1594057121649-d7e684c2768e9.jpg

#Novartis Q2 Earnings: Core European Markets Dragged Novartis Down

Stocks Decoded | Invest and trade with knowledge that drives profits and cuts risks

2 minutes 29 seconds

5 years ago

#Novartis Q2 Earnings: Core European Markets Dragged Novartis Down

Novartis reported second quarter earnings on July 21 after a strong first quarter fueled by COVID-related forward purchasing. As one of the worldwide leaders in the pharma industry, the Swiss-based company is certainly of interest to everyone who keeps an eye on pharmaceuticals and biotech for business or investments.

There is a new way to learn about stocks, markets, trading and companies. Now you can access it at www.robalyst.com.

#stocks #investing #healthcare #pharmaceuticals